
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Mnk1 CRISPR/Cas9 KO Plasmid (m) | sc-421657 | 20 µg | $397.00 | |||
Mnk1 HDR Plasmid (m) | sc-421657-HDR | 20 µg | $445.00 |
Mknk1 encodes MAP kinase-interacting serine/threonine-protein kinase 1 (Mnk1), a downstream effector of ERK and p38 MAPK signaling that modulates stimulus-dependent translation. Mnk1 phosphorylates eIF4E and influences cap-dependent mRNA translation, linking extracellular cues to programs controlling proliferation, stress responses, and inflammatory signaling. Through its integration with MAPK pathways and translational control machinery, Mknk1 is frequently studied in contexts of aberrant growth signaling and immune activation. Mouse Mnk1 models support mechanistic dissection of kinase-driven translational regulation in cancer biology, neuroinflammation, and metabolic stress paradigms.
Mnk1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Mknk1 gene in mouse cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the Mknk1 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, Mnk1 HDR Plasmid (m) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined Mknk1 target site.
When co-transfected with Mnk1 CRISPR/Cas9 KO Plasmid (m):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the Mknk1 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.